ask="0.8389"
ask_size="3000"
average_daily_volume="17581"
bid="0.0300"
bid_size="5000"
book_value="0.2800"
change="+0.1042"
change_from_200_day_moving_average="-0.1423"
change_from_50_day_moving_average="0.0972"
change_from_52_week_high="-0.8257"
change_From_52_week_low="0.2542"
change_in_percent="+15.7879%"
close="0.7642"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2600"
ebitda="-2.11M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="9122000"
high="0.7642"
high_52_weeks="1.5899"
last_trade_date="1/19/2017"
last_trade_price="0.7642"
last_trade_size="900"
last_trade_time="4:00pm"
low="0.6350"
low_52_weeks="0.5100"
market_capitalization="10.24M"
moving_average_200_day="0.9065"
moving_average_50_day="0.6670"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="6.0000"
open="0.6700"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-15.6975%"
percent_change_from_50_day_moving_average="+14.5779%"
percent_change_from_52_week_high="-51.9341%"
percent_change_from_52_week_low="+49.8431%"
previous_close="0.6600"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.3571"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.4000"
stock_exchange="NCM"
symbol="XTLB"
volume="132573"
weeks_range_52="0.5100 - 1.5899"
